{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:00:33Z","timestamp":1791219633721,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T00:00:00Z","timestamp":1703116800000},"content-version":"vor","delay-in-days":4281,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of nutrition, health and aging"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1007\/s12603-012-0044-x","type":"journal-article","created":{"date-parts":[[2012,5,8]],"date-time":"2012-05-08T22:20:30Z","timestamp":1336515630000},"page":"339-345","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Alzheimer's disease therapeutic trials: EU\/US task force report on recruitment, retention, and methodology"],"prefix":"10.1016","volume":"16","author":[{"given":"B.","family":"Vellas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Hampel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.E.","family":"Rouge-Bugat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Grundman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Andrieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Abu-Shakra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Bateman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Berman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Black","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Carrillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Donohue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Mintun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.G.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Suhy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Seely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Tariot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Touchon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Weiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Sampaio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Aisen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1007\/s12603-012-0044-x_bib1","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/ana.22365","article-title":"What the halted phase III gamma-secretase inhibitor trial may (or may not) be telling us","volume":"69","author":"Schor","year":"2011","journal-title":"Ann Neurol"},{"key":"10.1007\/s12603-012-0044-x_bib2","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.jalz.2011.05.2243","article-title":"The Alzheimer\u2019s Association external quality control program for cerebrospinal fluid biomarkers","volume":"7","author":"Mattsson","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.1007\/s12603-012-0044-x_bib3","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/S1474-4422(07)70178-3","article-title":"Research criteria for the diagnosis of Alzheimers disease: revising the N1NCDS ADRDA criteria","volume":"6","author":"Dubois","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1007\/s12603-012-0044-x_bib4","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/S1474-4422(10)70223-4","article-title":"Revising the definition of Alzheimer\u2019s disease: anew lexicon","volume":"9","author":"Dubois","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1007\/s12603-012-0044-x_bib5","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","article-title":"The diagnosis of mild cognitive impairment due to Alzheimer\u2019s disease: Recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"Albert","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.1007\/s12603-012-0044-x_bib6","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jalz.2011.03.004","article-title":"Introduction to revised criteria for the diagnosis of Alzheimer\u2019s disease: National Institute on Aging and the Alzheimer\u2019s Association workgroup","volume":"7","author":"Jack","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.1007\/s12603-012-0044-x_bib7","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer\u2019s disease: Recommendations from the National Institute on Aging and the Alzheimer\u2019s Association workgroup","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.1007\/s12603-012-0044-x_bib8","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","article-title":"Toward defining the preclinical stages of Alzheimer\u2019s disease: Recommendations from the National Institute on Aging and the Alzheimer\u2019s Association workgroup","volume":"7","author":"Sperling","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.1007\/s12603-012-0044-x_bib9","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1212\/WNL.0b013e31824365ab","article-title":"APOE modifies the association between Abeta load and cognition in cognitively normal older adults","volume":"78","author":"Kantarci","year":"2012","journal-title":"Neurology"},{"key":"10.1007\/s12603-012-0044-x_bib10","doi-asserted-by":"crossref","unstructured":"Schneider LS: Recruitment methods for United States Alzheimer disease prevention trials. J Nutr Health Aging. In Press (2012).","DOI":"10.1007\/s12603-012-0011-6"},{"key":"10.1007\/s12603-012-0044-x_bib11","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jalz.2009.01.018","article-title":"Commentary on \u201ca roadmap for the prevention of dementia II. Leon Thai Symposium 2008.\u201d A national registry to identify a cohort for Alzheimer\u2019s disease prevention studies","volume":"5","author":"Sabbagh","year":"2009","journal-title":"Alzheimers Dement"},{"key":"10.1007\/s12603-012-0044-x_bib18","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1007\/s12603-011-0142-1","article-title":"IAGG workshop: health promotion program on prevention of late onset dementia","volume":"15","author":"Andrieu","year":"2011","journal-title":"J Nutr Health Aging"},{"key":"10.1007\/s12603-012-0044-x_bib19","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/epirev\/mxn010","article-title":"Dementia prevention: methodological explanations for inconsistent results","volume":"30","author":"Coley","year":"2008","journal-title":"Epidemiol Rev"},{"key":"10.1007\/s12603-012-0044-x_bib20","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1212\/WNL.0b013e3181c67808","article-title":"A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease","volume":"73","author":"Salloway","year":"2009","journal-title":"Neurology"},{"key":"10.1007\/s12603-012-0044-x_bib21","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/nrd3115","article-title":"Biomarkers for Alzheimers disease: academic, industry and regulatory perspectives","volume":"9","author":"Hampel","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"10.1007\/s12603-012-0044-x_bib22","doi-asserted-by":"crossref","first-page":"881","DOI":"10.3233\/JAD-2010-091606","article-title":"Biomarkers as predictors for conversion from mild cognitive impairment to Alzheimer-type dementia: implications for trial design","volume":"20","author":"van Rossum","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"10.1007\/s12603-012-0044-x_bib23","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.pneurobio.2011.11.009","article-title":"Ethical considerations of biomarker use in neurodegenerative diseases-A case study of Alzheimer\u2019s disease","volume":"95","author":"Prvulovic","year":"2011","journal-title":"Prog Neurobiol"},{"key":"10.1007\/s12603-012-0044-x_bib24","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrneurol.2010.4","article-title":"Cerebrospinal fluid and plasma biomarkers in Alzheimer disease","volume":"6","author":"Blennow","year":"2010","journal-title":"Nat Rev Neurol"},{"key":"10.1007\/s12603-012-0044-x_bib25","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.tins.2011.05.005","article-title":"Neuroimaging markers for the prediction and early diagnosis of Alzheimer\u2019s disease dementia","volume":"34","author":"Ewers","year":"2011","journal-title":"Trends Neurosci"},{"key":"10.1007\/s12603-012-0044-x_bib26","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.pneurobio.2010.11.005","article-title":"Biomarkers for Alzheimer\u2019s disease therapeutic trials","volume":"95","author":"Hampel","year":"2011","journal-title":"Prog Neurobiol"},{"key":"10.1007\/s12603-012-0044-x_bib27","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.jalz.2011.05.2351","article-title":"Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: recommendations from the Alzheimer\u2019s Association Research Roundtable Workgroup","volume":"7","author":"Sperling","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.1007\/s12603-012-0044-x_bib28","unstructured":"Donohue MC, Aisen P (2012) Profile models versus slope models for assessing longitudinal change in Alzheimer\u2019s disease clinical trials. J Nutr Health Aging. In Press."},{"key":"10.1007\/s12603-012-0044-x_bib29","unstructured":"European Medicines Agency CHMP (2010) Guidelines on Missing Data in Confirmatory Clinical Trials. London, United Kingdom."},{"key":"10.1007\/s12603-012-0044-x_bib30","series-title":"The Prevention and Treatment of Missing Data in Clinical Trials","year":"2010"},{"key":"10.1007\/s12603-012-0044-x_bib31","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1001\/archneurol.2010.343","article-title":"Treatment with Cholinesterase inhibitors and memantine of patients in the Alzheimer\u2019s Disease Neuroimaging Initiative","volume":"68","author":"Schneider","year":"2011","journal-title":"Arch Neurol"},{"key":"10.1007\/s12603-012-0044-x_bib32","doi-asserted-by":"crossref","unstructured":"Hampel H, Prvulovic D (2012) Are biomarkers harmful to recruitment and retention in Alzheimer\u2019s disease clinical trials? An international perspective. J Nutr Health Aging. In Press.","DOI":"10.1007\/s12603-012-0021-4"},{"key":"10.1007\/s12603-012-0044-x_bib12","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1001\/jama.2009.1913","article-title":"Ginkgo biloba for preventing cognitive decline in older adults: a randomized trial","volume":"302","author":"Snitz","year":"2009","journal-title":"JAMA"},{"key":"10.1007\/s12603-012-0044-x_bib13","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jalz.2008.09.004","article-title":"Alzheimer\u2019s Disease Antiinflammatory Prevention Trial: design, methods, and baseline results","volume":"5","author":"Meinert","year":"2009","journal-title":"Alzheimers Dement"},{"key":"10.1007\/s12603-012-0044-x_bib14","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1212\/WNL.67.9_suppl_3.S6","article-title":"The GuidAge study: methodological issues. A 5-year double-blind randomized trial of the efficacy of EGb 761 for prevention of Alzheimer disease in patients over 70 with a memory complaint","volume":"67","author":"Vellas","year":"2006","journal-title":"Neurology"},{"key":"10.1007\/s12603-012-0044-x_bib15","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(02)09327-3","article-title":"MRC\/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo controlled trial","volume":"360","year":"2002","journal-title":"The Lancet"},{"key":"10.1007\/s12603-012-0044-x_bib16","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1001\/jama.289.20.2651","article-title":"Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women\u2019s Health Initiative Memory Study: a randomized controlled trial","volume":"289","author":"Shumaker","year":"2003","journal-title":"JAMA"},{"key":"10.1007\/s12603-012-0044-x_bib17","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/sim.1716","article-title":"Designing a large prevention trial: statistical issues","volume":"23","author":"Kryscio","year":"2004","journal-title":"Stat Med"}],"container-title":["The Journal of nutrition, health and aging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12603-012-0044-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12603-012-0044-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1279770723015543?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1279770723015543?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12603-012-0044-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T12:57:09Z","timestamp":1761137829000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1279770723015543"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S1279770723015543"],"URL":"https:\/\/doi.org\/10.1007\/s12603-012-0044-x","relation":{},"ISSN":["1279-7707"],"issn-type":[{"value":"1279-7707","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alzheimer's disease therapeutic trials: EU\/US task force report on recruitment, retention, and methodology","name":"articletitle","label":"Article Title"},{"value":"The Journal of nutrition, health and aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s12603-012-0044-x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2012 SERDI Publisher.","name":"copyright","label":"Copyright"}]}}